BION-1301 is a humanized antibody that blocks A PRoliferation-Inducing Ligand (APRIL) from binding to its receptors, using Aduro’s B-select monoclonal antibody platform. In preclinical studies, BION-1301 eliminated malignant cells and reduced resistance to therapy in models of multiple myeloma.
| SparkCures ID | 301 |
|---|---|
| Developed By | Aduro Biotech, Inc. |
| Generic Name | BION-1301 |
| Treatment Classifications | |
| Treatment Targets |
|
There are no resources, links or videos to display for this treatment.